NXP

NXP
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2024 | $16.961M ▲ | $-496.93K ▼ | $-10.501M ▼ | -61.91% ▼ | $-0.21 ▼ | $-10.226M ▼ |
| Q2-2024 | $15.982M ▲ | $833.597K ▲ | $20.045M ▼ | 125.422% ▼ | $0.41 ▼ | $19.77M ▲ |
| Q4-2023 | $15.356M ▲ | $795.62K ▲ | $54.819M ▲ | 356.994% ▲ | $1.14 ▲ | $0 |
| Q2-2023 | $14.823M ▲ | $775.262K ▼ | $-23.42M ▼ | -158.005% ▼ | $-0.49 ▼ | $0 |
| Q4-2022 | $14.533M | $33.358M | $47.892M | 329.528% | $1.02 | $0 |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2024 | $6.005M ▲ | $755.135M ▲ | $30.833M ▲ | $724.302M ▼ |
| Q2-2024 | $3.431M ▲ | $734.421M ▲ | $8.405M ▼ | $726.015M ▲ |
| Q4-2023 | $275.175K ▲ | $713.215M ▲ | $10.886M ▼ | $702.328M ▲ |
| Q2-2023 | $0 ▼ | $665.258M ▼ | $14.474M ▲ | $650.784M ▼ |
| Q4-2022 | $138.719K | $684.702M | $2.646M | $682.056M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2024 | $-10.501M ▼ | $0 | $0 | $0 | $0 | $0 |
| Q2-2024 | $20.045M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q4-2023 | $15.699M | $0 | $0 | $0 | $0 | $0 |
| Q2-2023 | $15.699M ▲ | $0 | $0 | $0 | $0 ▲ | $0 |
| Q4-2022 | $-149.6K | $0 | $0 | $0 | $-1.185M | $0 |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
NXP is a long‑standing, tax‑free municipal bond fund that has moved from a period of weaker results back to more normal, positive earnings as bond markets have stabilized. Its balance sheet is simple and conservative, with low leverage and assets largely matched by equity, aligning with its goal of capital preservation and steady income. Classic cash‑flow metrics add limited insight because this is an income‑distribution vehicle rather than an operating company. Competitively, the fund leans on Nuveen’s scale, municipal expertise, and in‑house research, including ESG analysis, to differentiate itself in a crowded field. Overall, NXP represents a cautious, research‑driven approach to tax‑free income, with outcomes closely tied to interest‑rate trends and the health of the municipal bond market.
NEWS
November 25, 2025 · 8:00 AM UTC
Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC
Read more
October 29, 2025 · 4:00 AM UTC
NXP Improves Battery Health Monitoring with EIS Capable Battery Management Chipset
Read more
October 28, 2025 · 7:45 AM UTC
NXP Completes Acquisitions of Aviva Links and Kinara to Advance Automotive Connectivity and AI at the Intelligent Edge
Read more
October 9, 2025 · 4:10 PM UTC
NXP Semiconductors Announces Conference Call to Review Third Quarter 2025 Financial Results
Read more
About Nuveen Select Tax-Free Income Portfolio
https://www.nuveen.com/CEF/Product/Overv...Nuveen Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of United States. The fund invests in the investment-grade municipal securities rated Baa and BBB or better.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2024 | $16.961M ▲ | $-496.93K ▼ | $-10.501M ▼ | -61.91% ▼ | $-0.21 ▼ | $-10.226M ▼ |
| Q2-2024 | $15.982M ▲ | $833.597K ▲ | $20.045M ▼ | 125.422% ▼ | $0.41 ▼ | $19.77M ▲ |
| Q4-2023 | $15.356M ▲ | $795.62K ▲ | $54.819M ▲ | 356.994% ▲ | $1.14 ▲ | $0 |
| Q2-2023 | $14.823M ▲ | $775.262K ▼ | $-23.42M ▼ | -158.005% ▼ | $-0.49 ▼ | $0 |
| Q4-2022 | $14.533M | $33.358M | $47.892M | 329.528% | $1.02 | $0 |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2024 | $6.005M ▲ | $755.135M ▲ | $30.833M ▲ | $724.302M ▼ |
| Q2-2024 | $3.431M ▲ | $734.421M ▲ | $8.405M ▼ | $726.015M ▲ |
| Q4-2023 | $275.175K ▲ | $713.215M ▲ | $10.886M ▼ | $702.328M ▲ |
| Q2-2023 | $0 ▼ | $665.258M ▼ | $14.474M ▲ | $650.784M ▼ |
| Q4-2022 | $138.719K | $684.702M | $2.646M | $682.056M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2024 | $-10.501M ▼ | $0 | $0 | $0 | $0 | $0 |
| Q2-2024 | $20.045M ▲ | $0 | $0 | $0 | $0 | $0 |
| Q4-2023 | $15.699M | $0 | $0 | $0 | $0 | $0 |
| Q2-2023 | $15.699M ▲ | $0 | $0 | $0 | $0 ▲ | $0 |
| Q4-2022 | $-149.6K | $0 | $0 | $0 | $-1.185M | $0 |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
NXP is a long‑standing, tax‑free municipal bond fund that has moved from a period of weaker results back to more normal, positive earnings as bond markets have stabilized. Its balance sheet is simple and conservative, with low leverage and assets largely matched by equity, aligning with its goal of capital preservation and steady income. Classic cash‑flow metrics add limited insight because this is an income‑distribution vehicle rather than an operating company. Competitively, the fund leans on Nuveen’s scale, municipal expertise, and in‑house research, including ESG analysis, to differentiate itself in a crowded field. Overall, NXP represents a cautious, research‑driven approach to tax‑free income, with outcomes closely tied to interest‑rate trends and the health of the municipal bond market.
NEWS
November 25, 2025 · 8:00 AM UTC
Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC
Read more
October 29, 2025 · 4:00 AM UTC
NXP Improves Battery Health Monitoring with EIS Capable Battery Management Chipset
Read more
October 28, 2025 · 7:45 AM UTC
NXP Completes Acquisitions of Aviva Links and Kinara to Advance Automotive Connectivity and AI at the Intelligent Edge
Read more
October 9, 2025 · 4:10 PM UTC
NXP Semiconductors Announces Conference Call to Review Third Quarter 2025 Financial Results
Read more

CEO
Thomas C. Spalding Jr.,
Compensation Summary
(Year 2024)

CEO
Thomas C. Spalding Jr.,
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : B
Institutional Ownership

UBS GROUP AG
1.354M Shares
$19.392M

GUGGENHEIM CAPITAL LLC
950.197K Shares
$13.607M

HENNION & WALSH ASSET MANAGEMENT, INC.
920.567K Shares
$13.183M

STEPHENS INC /AR/
496.123K Shares
$7.104M

CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.
452.024K Shares
$6.473M

BANK OF AMERICA CORP /DE/
431.687K Shares
$6.182M

MORGAN STANLEY
402.983K Shares
$5.771M

WELLS FARGO & COMPANY/MN
360.417K Shares
$5.161M

RAYMOND JAMES FINANCIAL INC
241.367K Shares
$3.456M

VAN ECK ASSOCIATES CORP
223.358K Shares
$3.198M

RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.
218.154K Shares
$3.124M

PROSPERA FINANCIAL SERVICES INC
203.595K Shares
$2.915M

COMMONWEALTH EQUITY SERVICES, LLC
199.5K Shares
$2.857M

JONES FINANCIAL COMPANIES LLLP
163.874K Shares
$2.347M

LPL FINANCIAL LLC
132.996K Shares
$1.905M

ROYAL BANK OF CANADA
105.681K Shares
$1.513M

UBS AG
98.556K Shares
$1.411M

MELFA WEALTH MANAGEMENT, LLC
90.037K Shares
$1.289M

AMERIPRISE FINANCIAL INC
72.573K Shares
$1.039M

RAYMOND JAMES & ASSOCIATES
70.202K Shares
$1.005M
Summary
Only Showing The Top 20

